ISNCC Position Statement on Tobacco

作者：Stella Aguinaga Bialous, Meinir Krishnasamy, Jane W. Marsh, Julia D. Downing, Winnie K.W. So, Patsy Yates · 发表于：Cancer Nursing · 年份：2023 · DOI：10.1097/ncc.0000000000001232 · 被引用次数：3 · 研究领域：Smoking Behavior and Cessation、Global Public Health Policies and Epidemiology、Air Quality and Health Impacts

A Global Health Issue Prevention of tobacco-related disease is a major global health issue. More than 8 million tobacco-related deaths occur globally every year,1 the majority of these in low- and middle-income countries, where greater than 80% of the world’s 1.3 billion tobacco users live.1,2 Despite advances achieved through the World Health Organization (WHO) Framework Convention on Tobacco Control,3 tobacco and other nicotine products continue to be a major threat to global health and a leading cause of preventable death, disease, and suffering.1 In addition, the global financial cost is significant, and in 2019, the direct and indirect economic costs of tobacco use and exposure worldwide were estimated at US $1.85 trillion.4 Accelerating efforts to support tobacco users to quit and prevent youth from starting is a global imperative. Nine of 10 smokers start before the age of 25 years, and across the globe, approximately 155 million people are smokers.3 Entry into the global market of several novel tobacco and nicotine delivery products, also known as electronic nicotine delivery systems (ENDS), has created an additional need for vigilance to ensure that a new generation of young people does not become addicted to nicotine.5 Although in some controlled instances these products have been associated with cessation of cigarette use,6 their safety and toxicity are not yet well established, and their usefulness as a tobacco use cessation tool on a population level is yet to be...